

Please try another search
(Reuters) - Activist investor Carl Icahn is preparing a proxy fight at Illumina Inc (NASDAQ:ILMN), arguing that the life science maker's acquisition of Grail Inc cost its shareholders roughly $50 billion, the Wall Street Journal reported on Sunday.
Illumina completed a takeover of cancer-detection test maker Grail in August 2021, without securing regulatory approval from the European Union. The European Commission ordered Illumina in December to unwind the deal, three months after it had blocked the merger on concerns the deal would stifle innovation.
Icahn plans to nominate three people to Illumina's board, the WSJ report said, citing a letter the billionaire plans to send to the shareholders on Monday.
"We are convinced that at least three shareholder representatives are needed on Illumina's board to attempt to put an end to this insanity now before the reckless decision making escalates into a no-return situation," Icahn wrote in the letter, according to the WSJ.
Icahn in the letter said his nominees - Vincent Intrieri, the founder and chief executive officer of an investment fund, and two of his deputies Jesse Lynn and Andrew Teno - would bring experience dealing with crises to the board.
Icahn wrote that he tried to strike a deal with Illumina to avoid a proxy battle.
Illumina declined to comment on the report while Carl Icahn did not immediately respond to a Reuters request for comment.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.